Hyeon Jin Kim

Hyeon Jin Kim

Auto-generated profile, based on publicly available information

Hyeon Jin Kim

Department of Epigenetics, Van Andel Institute, Grand Rapids, MI

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2026 in Blood Neoplasia
Verified
Journal Article
Open access
HJH. Josh Jang
H. Josh Jang
GUGuillermo Urrutia
Guillermo Urrutia
AØAndreas Due Ørskov
Andreas Due Ørskov
ANAnh Van Nguyen
Anh Van Nguyen
HKHyeon Jin Kim
Hyeon Jin Kim
PJPeter A. Jones
Peter A. Jones
• Baseline marrow inflammation and senescence limit immune activation after epigenetic and immune checkpoint therapy. • Durable survival is marked by interferon-driven immune reinvigoration and depletion of suppressive myeloid cells.